Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04139434 |
| Title | Dose-escalation Study of Oral Administration of LP-108 in Patients With Relapsed or Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Newave Pharmaceutical Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
| University of Cincinnati | Cincinnati | Ohio | 45221 | United States | Details | |
| Ohio State Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Institut Català d'oncologia - ICO Badalona | Badalona | Barcelona | 08916 | Spain | Details | |
| Hospital San Pedro de Alcántara | Cáceres | 10003 | Spain | Details | ||
| Instituto de Investigación Sanitaria La Fe | Valencia | CP 46026 | Spain | Details |